Urol. praxi. 2019;20(2):58-61 | DOI: 10.36290/uro.2019.050

The importance of phytopharmaceuticals in treating chronic prostatitis

PharmDr. MVDr. Vilma Vranová, Ph.D.
VFU Brno, Ústav aplikované farmacie, Farmaceutická fakulta Brno

Inflammatory diseases of the prostate are the most frequent urological diagnosis in men younger than 50 years, ranking as third in older age groups. An acute inflammation is relatively rare, with chronic inflammations being more common and posing much greater diagnostic and therapeutic challenges, which, as has been shown in many clinical trials, can be significantly influenced by the fact that the causative agents of prostatitis form biofilms. Making biofilm formation difficult or impossible reduces the fighting capacity of the pathogens while facilitating further treatment, e.g. increasing the effect of antimicrobial therapy. A synergistic effect with antibiotics has been shown in in-vitro studies for a number of plant essential oils, with rosemary oil having been shown very effective in treating urinary tract infection.

Keywords: prostatitis, biofilm, phytopharmaceuticals, essential oils, Rosmarinus officinalis

Published: May 17, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vranová V. The importance of phytopharmaceuticals in treating chronic prostatitis. Urol. praxi. 2019;20(2):58-61. doi: 10.36290/uro.2019.050.
Download citation

References

  1. Abrahámová, et al. Doporučený postup pro léčbu vybraných urologických onemocnění. Centrum doporučených postupů pro praktické lékaře 2011.
  2. Belej K. Prostatický syndrom. Urolog. pro Praxi, 2007; 2: 66-69.
  3. Nickel JC, Costerton JW. Bacterial localization in antibiotic-refractory chronic bacterial prostatitis, Prostate 1993; 23: 107-114. Go to original source... Go to PubMed...
  4. Nickel JC, Olson ME, et al. Pathogenesis of chronic bacterial prostatitis in an animal model, Br. J. Urol. 1990; 66: 47-54. Go to original source... Go to PubMed...
  5. Kanamaru S, et al. Increased biofilm formation in Escherichia coli isolated from acute prostatitis. Int J Antimicrob Agents 2006; 28(Suppl1): S21-S25. Go to original source... Go to PubMed...
  6. Nickel JC, Costerton JW. Coagulase-negative staphylococcus in chronic prostatitis. J Urol 1992; 147: 398-401. Go to original source... Go to PubMed...
  7. Arakawa S, Matsuit T, et al Prostatitis - the Japanese viewpoint. Int J Antimicrob Agents 1999; 11: 201-203. Go to original source... Go to PubMed...
  8. Choong S, Whitfield H. Biofilms and their role in infections in urology. BJU Int 2000; 86: 935-941. Go to original source... Go to PubMed...
  9. Surgers L, Boyd A, et al. Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella Pneumoniae. International Journal of Medical Microbiology 2019; 309: 13-18. Go to original source... Go to PubMed...
  10. Lhotský J. Úvod do studia symbiotických interakcí mikroorganismů: nový pohled na viry a bakterie. Praha: Academia, 2015.
  11. Antunes L, Caetano M. Quorum sensing in bacterial virulence. Microbiology. 2010, 156(8): 2271-2282. Go to original source... Go to PubMed...
  12. Sienkiewicz M, Lysakowska M, et al. The Potential of Use Basil and Rosemary Essential Oils as Effective Antibacterial Agents. Molecules 2013; 18: 9334-9351. Go to original source... Go to PubMed...
  13. Yap, et al. Essential Oils, A New Horizon in Combating Bacterial Antibiotic Resistance. The Open Microbiology Journal, 2014, 8: 6-14. Go to original source... Go to PubMed...
  14. Rosato, et al. Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin. Phytomedicine 2007; 14(11): 727-732. Go to original source... Go to PubMed...
  15. Abdulhasan G. Synergism effect of rosemary essential oil and some antibiotic against Escherichia coli isolated from clinical samples. IOSR Journal of Pharmacy and Biological Sciences. 2017; 12: 39-42. Go to original source...
  16. Sasahara Z. Biofilm formation by Listeria monocytogenes utilizes a primary colonizing microorganism in flowing systems. Journal of Food Protection, 1993; 56(12): 1022-1028. Go to original source... Go to PubMed...
  17. Horne D, Holm M, et al. Antimicrobial effects of essential oils on Staphylococcus pneumoniae. J Essential Oil Res 2001; 13: 387-392. Go to original source...
  18. Kumarasamy, et al. Bioactivity of gentiopicroside from the aerial parts of Centaurium erythraea, Fitoterapia 2003; 74: 151-154. Go to original source... Go to PubMed...
  19. SI H, et al. Antibacterial effect of oregano essential oil alone and in combination with antibiotics against extended-spectrum ?-lactamase-producing Escherichia coli. FEMS Immunol Med Microbiol 2008; 53: 190-194. Go to original source... Go to PubMed...
  20. Abdulhasan GA, Alzubaidy SK, et al. Effect of sub-inhibitory and inhibitory concentrations of some antibiotics and rosemary essential oil (Rosmarinus officinalis L.) on biofilm formation of Klebsiella pneumoniae. World J Exp Biosci 2016; 4: 130-135.
  21. Ghusoon, et al. Synergism effect of rosemary essential oil and some antibiotic against Escherichia coli isolated from clinical samples. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) 2017; 12(2): 39-42. Go to original source...
  22. Tawab AA, El-hofy FI, et al. Synergistic effect between some antimicrobial agents and rosemary (Rosmarinus officinalis) toward Staphylococcus aureus - in-vitro. Benha Vet Med J 2015; 28: 195-201. Go to original source...
  23. Shaaban HA, Ahmed MBM, et al. Study on the antimicrobial activity and synergistic/antagonistic effect of interactions between antibiotics and some spice essential oils against pathogenic and food-spoiler microorganisms. J Appl Sci Res 2013; 9: 5076-5085.
  24. van Vuuren, et al. The antimicrobial aktivity of four commercial essential oils in combination with conventional antimicrobials. Lett Appl Microbiol 2009; 48(4): 440-446. Go to original source... Go to PubMed...
  25. Steenkamp V. Phytomedicines for the prostate. Fitoterapia 2003; 74: 545-552. Go to original source... Go to PubMed...
  26. Chrubasik, et al. A comprehensive review on the stinging nettle effect and efficacy profiles. Phytomedicine 2007; 14: 568-579. Go to original source... Go to PubMed...
  27. Hassani, et al. Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review. Naunyn Schmiedebergs Arch Pharmacol. 2016; 389(9): 931-949. Go to original source... Go to PubMed...
  28. Moore, et al. Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols. Nutrients. 2016; Nov 17; 8(11). Go to original source... Go to PubMed...
  29. Ebrahimi A, et al. Antibacterial and Antibiotic-Potentiation Activities of Levisticum officinale L. Extracts on Pathogenic Bacteria, Int J Infect. 2017; 4(2): e38768. Go to original source...
  30. Kumarasamy, et al. Bioactivity of secoiridoid glycosides from Centaurium erythraea. Phytomedicine 2003; 10: 344-347. Go to original source... Go to PubMed...
  31. Šiler, et al. Centauries as underestimated food additives: Antioxidant and antimicrobial potential. Food Chemistry 2014; 147: 367-376. Go to original source... Go to PubMed...
  32. Šimandl O. Volně prodejné prostředky v terapii benigní hyperplazie prostaty Prakt. lékáren. 2016; 12(3): 111-117. Go to original source...
  33. Gravas, et al. Management of Non-neurogenic Male LUTS. [Online] [cit. 2019-03-19]. Dostupné z: https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.